Evidence map›Paper›PMID 26051180›Full record

ArticleMolecular cell2015

HLTF's Ancient HIRAN Domain Binds 3' DNA Ends to Drive Replication Fork Reversal.

Andrew C Kile, Diana A Chavez, Julien Bacal, Sherif Eldirany, Dmitry M Korzhnev, Irina Bezsonova, Brandt F Eichman, Karlene A Cimprich

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 202 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Andrew C KileDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Diana A ChavezDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA.
Julien BacalDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sherif EldiranyDepartment of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT 06032, USA.
Dmitry M KorzhnevDepartment of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT 06032, USA.
Irina BezsonovaDepartment of Molecular Biology and Biophysics, University of Connecticut Health Center, Farmington, CT 06032, USA.
Brandt F EichmanDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA. Electronic address: brandt.eichman@vanderbilt.edu.
Karlene A CimprichDepartment of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA 94305, USA. Electronic address: cimprich@stanford.edu.
UConn Health · USStanford University · USVanderbilt University · USStanford Medicine · US

Funding

Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
Vanderbilt/Meharry Initiative for Minority Student DvptR25GM062459 · NIGMS · VANDERBILT UNIVERSITY · PI VELEZ EDWARDS, DIGNA R · 2002 to 2020
$10.4M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Regulation of the DNA Damage ResponseR01ES016486 · NIEHS · STANFORD UNIVERSITY · PI CIMPRICH, KARLENE A · 2007 to 2025
$6.2M
TUMOR BIOLOGYT32CA009151 · NCI · STANFORD UNIVERSITY · PI CLEARY, MICHAEL L · 1985 to 2014
$5.5M
NCI NIH HHS T32 CA009151NCI NIH HHS T32 CA09151NIEHS NIH HHS P30 ES000267NIEHS NIH HHS R01 ES016486NIGMS NIH HHS R25 GM062459NIGMS NIH HHS T32 GM008320NIGMS NIH HHS T32 GM08320
6 · The paper itself

Abstract

Stalled replication forks are a critical problem for the cell because they can lead to complex genome rearrangements that underlie cell death and disease. Processes such as DNA damage tolerance and replication fork reversal protect stalled forks from these events. A central mediator of these DNA damage responses in humans is the Rad5-related DNA translocase, HLTF. Here, we present biochemical and structural evidence that the HIRAN domain, an ancient and conserved domain found in HLTF and other DNA processing proteins, is a modified oligonucleotide/oligosaccharide (OB) fold that binds to 3' ssDNA ends. We demonstrate that the HIRAN domain promotes HLTF-dependent fork reversal in vitro through its interaction with 3' ssDNA ends found at forks. Finally, we show that HLTF restrains replication fork progression in cells in a HIRAN-dependent manner. These findings establish a mechanism of HLTF-mediated fork reversal and provide insight into the requirement for distinct fork remodeling activities in the cell.

Indexed as

DNA ReplicationAmino Acid SequenceBase SequenceBinding SitesBlotting, WesternCell Line, TumorCrystallography, X-RayDNADNA-Binding ProteinsDNA, Single-StrandedHumansMagnetic Resonance SpectroscopyModels, GeneticModels, MolecularMolecular Sequence DataMutationDNADNA-Binding ProteinsDNA, Single-StrandedHLTF protein, humanTranscription Factors

Identifiers

PMID26051180
PMCPMC4475461
OpenAlexW1873662011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.